Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment

Area of Science:

• Biomedical Engineering
• Cancer Research
• Microfluidics

Background:

• Solid tumors exhibit abnormal vasculature and hypoxia, driving cancer progression and therapeutic resistance.
• Existing in vitro models lack the physiological complexity to study tumor angiogenesis under hypoxia.
• Hypoxia, a key factor in tumor microenvironments, stimulates angiogenesis.

Purpose of the Study:

• To engineer a novel composite microdevice-microfluidics platform that recapitulates a vascularized hypoxic tumor.
• To enable high-content spatiotemporal analyses for mechanistic studies and therapeutic evaluations.
• To provide a physiologically relevant in vitro model for studying tumor angiogenesis and therapeutic delivery.

Main Methods:

• Engineered a composite microdevice-microfluidics platform with endothelial cells forming vascular lumens.
• Incorporated a hypoxic tumor section composed of cancer cells in a 3-D hydrogel extracellular matrix.
• Utilized microscopy-based high-content analyses for tracking vascular phenotypes, morphology, and sprouting over 7 days.

Main Results:

• Successfully recapitulated a vascularized hypoxic tumor model in vitro.
• Demonstrated tracking of vascular phenotypes, morphology, and sprouting into the hypoxic tumor section.
• Evaluated vascular lumen integrity for molecular delivery and immune cell trafficking.

Conclusions:

• The new platform accurately models vascularized hypoxic tumors, offering a significant advancement in cancer research.
• It facilitates mechanistic studies of tumor angiogenesis and evaluation of therapeutic delivery and efficacy.
• This model is valuable for understanding complex tumor microenvironment interactions and developing new cancer therapies.